Veregen
Generic name: kunecatechins
Treatment for: Condylomata Acuminata
MediGene Announces FDA Acceptance of New Drug Application for Polyphenon E Ointment for the Treatment of Genital Warts
The active substance in Polyphenon E Ointment is a green tea extract with a defined catechin composition. MediGene is developing this drug for the treatment of various skin tumors.
Genital Warts
Genital warts are one of the most common and fastest spreading venereal diseases worldwide. Genital warts are benign, but disfiguring and contagious skin tumors in the genital and anal area, which are difficult to treat. Approximately 14 million people in North America and 15 million people in Europe are infected by human papilloma viruses (HPV type 6 or 11), which cause genital warts.
Source: MediGene AG
Posted: December 2005
Related articles
- Polyphenon E MediGene AG - Treatment for Genital and Perianal Warts - October 31, 2006
- FDA Extends PDUFA Date for Polyphenon E Ointment to October 31, 2006 - June 30, 2006
Veregen (kunecatechins) FDA Approval History
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.
